IL6 and systemic lupus erythematosus: Compared with healthy controls, patients with systemic lupus erythematosus (SLE) have higher serum levels of IFN-III (58), which is also correlated with the upregulation of inflammatory cytokines including IL-6, IL-27, Th17, and B cell activating factor (BAFF) (59–61).